To examine whether the reduction in mTORC1 activity contributed to attenuated toxicity of PIs, we treated MM cells, in which mTORC1 is constitutively activated by deletion of TSC2 or NPRL2, with IXZ. Here, TSC2 is linked to Miyoshi myopathy.